Cancer statistics, 2016.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal
https://pubmed.ncbi.nlm.nih.gov/26742998/Actively Recruiting
Led by United States Naval Medical Center, Portsmouth · Updated on 2024-11-19
200
Participants Needed
1
Research Sites
13 weeks
Total Duration
Researchers are comparing how long pain relief lasts between two types of local anesthetic combinations used during erector spinae plane blocks for patients undergoing mastectomy surgery for breast cancer. This trial aims to see if adding dexmedetomidine to bupivacaine provides longer or more effective pain control than using liposomal bupivacaine with bupivacaine alone. The study measures differences in pain relief duration and the amount of opioid pain medication needed after surgery. Participants will receive an erector spinae plane block guided by ultrasound performed by the Acute Pain Service team. Patients are randomly assigned by month to receive either bupivacaine 0.25% with liposomal bupivacaine or bupivacaine 0.25% with dexmedetomidine. The local anesthetic is delivered using a needle placed under direct visualization into the erector spinae plane, with doses adjusted by patient weight and surgical side. All patients receive 10 mg intravenous dexamethasone after anesthesia induction. During the hospital stay, pain scores and opioid use in morphine equivalents are recorded every 6 hours starting in the recovery area until discharge. After discharge, participants are contacted at 72 hours to report daily pain scores and opioid tablet use since leaving the hospital. The primary outcome is the density and duration of pain relief over 96 hours, while secondary measures include total oral opioid consumption during the same period.
CONDITIONS
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies
G
Grant A Miller, DO
T
Trevor O Elam, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
United States Naval Medical Center, Portsmouth
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Bupivacaine + Dexmedetomidine Nerve Block | Liposomal Bupivacaine Nerve Block |
|---|---|---|
| What it is | A nerve block using standard bupivacaine with dexmedetomidine as an additive to potentially improve and prolong the pain-relieving effect after breast surgery. | A nerve block utilizing both liposomal bupivacaine, a long-acting formulation, and plain bupivacaine to provide extended-duration pain control following mastectomy. |
| Role in this trial | Evaluated as an investigational intervention to test if adding dexmedetomidine to bupivacaine enhances nerve block effectiveness compared to the other regimen. | Serves as the active comparator to assess if combined liposomal and plain bupivacaine provides equally effective or superior pain relief. |
| Primary use | To offer perioperative pain relief for patients undergoing mastectomy by extending block duration through the use of dexmedetomidine. | To provide long-lasting pain control after mastectomy using a slow-release bupivacaine formulation. |
| How it is given or performed | A single erector spinae plane block is performed using ultrasound guidance, injecting a mixture of bupivacaine plain and dexmedetomidine before surgery. | A single erector spinae plane block is performed with both liposomal bupivacaine and plain bupivacaine injected under ultrasound guidance prior to surgery. |
| Evidence status | Multiple studies, including systematic reviews, suggest dexmedetomidine added to bupivacaine significantly increases duration of nerve block and reduces early postoperative pain. | Randomized trials and meta-analysis show liposomal bupivacaine extends postoperative analgesia versus plain bupivacaine, but benefit over adjunct-enhanced blocks (such as with dexmedetomidine) is less certain. No consistent superiority over adjuvant-extended blocks. |
| Important limitations | Potential for off-label use of dexmedetomidine and risk of side effects such as bradycardia or sedation; efficacy may vary depending on block technique. | Higher cost and product availability may limit use. Results are variable across different block types and surgical procedures, with inconsistent additional benefit over standard local anesthetic blocks. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day (day of surgery)
Participants receive an erector spinae plane block with either liposomal bupivacaine or bupivacaine with dexmedetomidine to manage postoperative pain after mastectomy surgery.
1 visit during surgery (in-person)
Duration - Up to 4 days after surgery
Participants are monitored for pain scores and medication usage every 6 hours while in the hospital and contacted at home for pain assessment daily up to 72 hours after discharge.
Frequent in-hospital assessments every 6 hours until discharge, plus 1 follow-up call at 72 hours post-discharge
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal
https://pubmed.ncbi.nlm.nih.gov/26742998/Nicholas T Haddock, Ricardo Garza, Carolyn E Boyle...
https://pubmed.ncbi.nlm.nih.gov/34705768/Alexandre Nguyen, Sina Grape, Mattia Gobbetti...
https://pubmed.ncbi.nlm.nih.gov/37038770/Shawn H Malan, Dawn E Jaroszewski, Ryan C Craner...
https://pubmed.ncbi.nlm.nih.gov/37121043/F W Abdallah, R Brull
https://pubmed.ncbi.nlm.nih.gov/23587874/A Schnabel, S U Reichl, P Kranke...
https://pubmed.ncbi.nlm.nih.gov/20947592/David H Kim, Jiabin Liu, Jonathan C Beathe...
https://pubmed.ncbi.nlm.nih.gov/35041742/Eric Albrecht, Leon Vorobeichik, Alain Jacot-Guillarmod...
https://pubmed.ncbi.nlm.nih.gov/30303864/Ciara A Brown, Arian Ghanouni, Rachel Williams...
https://pubmed.ncbi.nlm.nih.gov/36752544/Christina W Fidkowski, Nandak Choksi, Mohamed-Rida Alsaden
https://pubmed.ncbi.nlm.nih.gov/33432496/United States Naval Medical Center, Portsmouth
Lead Sponsor